What the FDA's Botox Warning Letter Means for DSCSA Compliance

In this episode, Gabe Scott, Natalia Nino, and Darrell White discuss the Drug Supply Chain Security Act following the FDA's warning letter to a medical spa over Botox products. T h eir conversation explores what the enforcement action reveals about the agency's compliance expectations, what it may signal about the F DA's priorities , and the steps dispensers should be taking now to mitigate risk…